Skip to content

Effect of test food consumption on tear secretion and physical condition.

Effect of test food consumption on tear secretion and physical condition. - Effect of test food consumption on tear secretion and physical condition.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029577
Enrollment
50
Registered
2017-10-17
Start date
2017-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Subjects take 200mL test food every morning in daily life for 3 weeks. Subjects take 200mL placebo every morning in daily life for 3 weeks.

Sponsors

Kyodo Milk Industry Co. Ltd. Research Laboratories
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healthy adults 2.Subjects who feel eye dryness

Exclusion criteria

Exclusion criteria: 1. Subjects under treatment of eyes 2. Subjects who operated or plan an operation for eyes within three months of screening test 3. Subjects who have serious or progressive illness and symptom 4. Subjects who routinely take pharmaceutical, quasi drug or health food, which may influence the result of this trial (including foods containing oligosaccharide, dietary fiber, hydrogen water and supplements that produce hydrogen gas) 5. Subjects who can avoid the intake of milk and dairy products except test food from screening examination to three weeks later 6. Subjects who have food allergies or drug allergies 7. Subjects with serious lactose intolerance (diarrhea) 8. Subjects who have serious constipation which need to take cathartic drugs and laxative products 9. Subjects under treatment of dry eye 10. Subjects who were enrolled in other trails within one month of screening test 11. Female Subjects who are or might become pregnant 12. Subjects who have history of serious hepatic disorder, renal damage, or myocardial infarction 13. Subjects who have been receiving drug treatment 14. Subjects with severe anemia 15. Inappropriate cases evaluated by doctors

Design outcomes

Primary

MeasureTime frame
BUT, Schirmer's test, Questionnaire about ocular symptoms

Secondary

MeasureTime frame
Fecal microbiota, breath hydrogen concentration, oxidative-stress marker in tear, and questionnaire

Countries

Japan

Contacts

Public ContactYoshitada Hira

imeQ CO. Ltd. CRO division

y-hira@imeq.co.jp03-6205-6222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026